ABBV AbbVie Inc.
P/E
114.35784
Forward P/E
14.417749
Price/Sales
6.561312
Beta
0.309
Div Yield
0.029500000000000002%
Market Cap
--
Company Analysis
Latest News
AbbVie Receives Expanded FDA Approval for RINVOQ® in Inflammatory Bowel Disease, Boosting Treatment Options
On October 13, 2025, AbbVie announced it received approval from the U.S. Food and Drug Administration (FDA) for a supplemental New Drug Application (sNDA) for...
Piper Sandler Raises AbbVie Price Target to $284, Maintains Overweight Rating
On October 10, 2025, Piper Sandler raised its price target for AbbVie Inc (ABBV) from $231.00 to $284.00 while maintaining an 'Overweight' rating, signaling...